Ravidasvir

Generic Name
Ravidasvir
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C42H50N8O6
CAS Number
1242087-93-9
Unique Ingredient Identifier
AL3G001BI8
Background

Ravidasvir is under investigation in clinical trial NCT02961426 (Sofosbuvir Plus Ravidasvir for the Treatment of HCV Chronic Infection).

Indication

联合利托那韦强化的达诺瑞韦钠片和利巴韦林,用于治疗初治的基因1b型慢性丙型肝炎病毒感染的非肝硬化成人患者,不得作为单药治疗。

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath